New experimental observation on the relationship of selenium and diabetes mellitus
Selenium shows insulin-mimic properties in vitro and in vivo. However, in this study, a high dose of 4 mg/kg/d selenite orally administered to the alloxan-induced diabetic Kun-Ming mice for 4 wk failed to reduce hyperglycemia. Se contents in plasma and tissues such as the liver, kidney, spleen, and brain were determined and the thiobarbituric acid-reactive substances (TBARS) levels were investigated. The results showed that alloxan-induced diabetes did not cause a significant decrease in Se levels in plasma and the above tissues compared to the normal control, but selenite treatment significantly increased Se levels in plasma, liver, and brain of the selenite-treated diabetic mice compared to the nontreated diabetic mice. In addition, selenite treatment for diabetic mice reduced the TBARS levels in red blood cells (RBCs) compared to the normal and improved the glutathione peroxidase (GSH-Px) levels in RBCs significantly compared to the diabetic control. In conclusion, this study demonstrated that although oral administration of a high dose of selenite had no hypoglycemic effect on diabetic mice in 4 wk, selenite treatment still maintained the antioxidant beneficial effect on the diabetic mice. This study shed more light on the relationship between Se and diabetes.
Index EntriesSelenite diabetes Se level lipid peroxidation GSH-Px
X. Chen, G. Yang, J. Chen, et al., Studies on the relations of selenium and Keshan disease, Biol. Trace Element Res.
, 91–107 (1980).Google Scholar
H. Xu and K. Huang, Selenium: Its Chemistry, Biochemistry and Application in Life Science
, Publishing Press of HUST, Beijing, pp. 104–139 (1994).Google Scholar
O. Ezaki, The insulin-like effects of sodium selenate in rat adipocytes, J. Biol. Chem.
, 1124–1128 (1990).PubMedGoogle Scholar
J. H. McNeill, H. L. M. Delgatty, and M. L. Battell, Insulinlike effects of sodium selenate in streptozotocin diabetic rats, Diabetes
, 1675–1678 (1991).CrossRefPubMedGoogle Scholar
R. Ghosh, B. Mukherjee, and M. Chatterjee, A novel effect of selenium on streptozotocin-induced diabetic mice, Diabetes Res.
, 165–171 (1994).PubMedGoogle Scholar
D. J. Becker, B. Reul, A. T. Ozcelikay, et al., Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats, Diabetologia
, 3–11 (1996).CrossRefPubMedGoogle Scholar
H. Xu, K. Huang, Y. Zhu, et al., Hypoglycemic effect of a novel insulin buccal formulation on rabbits, Pharmacol. Res.
, 459–467 (2002).CrossRefPubMedGoogle Scholar
M. L. Battell, H. L. M. Delgatty, and J. H. McNeill, Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats, Mol. Cell. Biochem.
, 27–34 1998.CrossRefPubMedGoogle Scholar
J. H. Wathinson, Fluorometric determination of selenium in biological material with 2,3-diaminonapaphthalene, Anal. Chem.
, 92–96 (1966).CrossRefGoogle Scholar
Z. A. Placer, L. Cushman, and B. C. Johnson, Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems, Anal. Biochem.
, 359–364 (1966).CrossRefPubMedGoogle Scholar
M. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein, Anal. Biochem.
, 248–258 (1974).CrossRefGoogle Scholar
D. G. Hafeman, R. A. Sunde, and W. G. Hoekstra, Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat, J. Nutr.
, 580–587 (1974).PubMedGoogle Scholar
H. Ding, R. Pen, J. Chen, et al., Effect of selenite and allitridi
on the diabetic mice, Acta Nutr. Sini
, 384–387 (1997).Google Scholar
J. Meyerovitch, Z. Farfelsn, J. Sack, et al., Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats—characterization and mode of action, J. Biol. Chem.
, 6658–6662 (1987).PubMedGoogle Scholar
S. R. Stapleton, G. L. Garlock, L. Foellmi-Adams, et al., Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase, Biochim. Biophys. Acta
, 259–269 (1997).CrossRefPubMedGoogle Scholar
E. A. Berg, J. Y. Wu, L. Campbell, et al., Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats, Biochimie
, 919–924 (1995).CrossRefGoogle Scholar
C. Fürnsinn, R. Englisch, K. Ebner, et al., Insulin-like vs. non-insulin-like stimulation of glucose metabolism by vanadium, tungsten, and selenium compounds in rat muscle, Life Sci.
, 1989–2000 (1996).CrossRefPubMedGoogle Scholar
T. S. Pillay and M. W. Makgoba, Enhancement of EGF and insulin-stimulated tyrosine phosphorylation of endogenous substrates by sodium selenate, FEBS Lett.
, 38–42 (1992).CrossRefPubMedGoogle Scholar
Y.-J. Hei, S. Farahbakhshian, X. Chen, et al., Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes, Mol. Cell. Biochem.
, 367–375 (1998).CrossRefPubMedGoogle Scholar
M. Navarro-Alarcón and M. C. López-Martínez, Essentiality of selenium in the human body: relationship with different diseases, Sci. Total Environ.
, 347–371 (2000).CrossRefPubMedGoogle Scholar
C. Ekmekcioglu, C. Prohaska, K. Pomazal, et al., Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls, Biol. Trace Element Res.
, 205–219 (2001).CrossRefGoogle Scholar
C. Ruiz, A. Alegria, R. Barbera, et al., Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states, J. Trace Elements Med. Biol.
, 91–95 (1998).Google Scholar
M. A. Beilstein and P. D. Whanger, Chemical forms of selenium in rat tissues after administration of selenite or selenomethionine, J. Nutr.
, 1711–1719 (1986).PubMedGoogle Scholar
T. Kato, R. Read, J. Tozga, et al., Evidence for intestinal release of absorbed selenium in a form with high hepatic extraction, Am. J. Physiol.
, G854-G858 (1992).PubMedGoogle Scholar
Y.-C. Park and P. D. Whanger, Toxicity, metabolism and absorption of selenite by isolated rat hepatocytes, Toxicology
, 151–162 (1995).CrossRefPubMedGoogle Scholar
A. L. McCall, The impact of diabetes on the CNS, Diabetes
, 557–570 (1992).CrossRefPubMedGoogle Scholar
A. D. Mooradian, Diabetic complications of the central nervous system, Endocr. Rev.
, 346–356 (1988).PubMedCrossRefGoogle Scholar
C. Chen and H. Xu, Study on the relationship of concentration of selenium biological effect and oxygen free radical by chemical system, Acta Nutr. Sini.
, 57–60 (1996).Google Scholar
H. Xu, X. Yang, Q. Liu, et al., The signal transduction in ROS-mediated apoptosis induced by selenium compounds, Prog. Chem.
, 305–310 (2002).Google Scholar